These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 11583472

  • 1. Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3.
    Kobayashi T, Homma Y.
    J Clin Pharmacol; 2001 Oct; 41(10):1055-8. PubMed ID: 11583472
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E phenotype associations with plasma lipoproteins and bone mass in postmenopausal women.
    Sanada M, Nakagawa H, Kodama I, Sakasita T, Ohama K.
    Climacteric; 1998 Sep; 1(3):188-95. PubMed ID: 11907943
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4.
    Eto M, Sato T, Watanabe K, Iwashima Y, Makino I.
    Atherosclerosis; 1990 Sep; 84(1):49-53. PubMed ID: 2248620
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study.
    Srinivasan SR, Ehnholm C, Wattigney WA, Berenson GS.
    Atherosclerosis; 1996 Nov 15; 127(1):73-9. PubMed ID: 9006807
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Apolipoprotein E phenotypes and plasma lipids in young and middle-aged subjects.
    Eto M, Watanabe K, Iwashima Y, Morikawa A, Oshima E, Sekiguchi M, Ishii K.
    Tohoku J Exp Med; 1986 Jan 15; 148(1):25-34. PubMed ID: 3705062
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4.
    Muros M, Rodríguez-Ferrer C.
    Atherosclerosis; 1996 Mar 15; 121(1):13-21. PubMed ID: 8678918
    [Abstract] [Full Text] [Related]

  • 16. The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.
    O'Malley JP, Illingworth DR.
    Metabolism; 1990 Feb 15; 39(2):150-4. PubMed ID: 2299987
    [Abstract] [Full Text] [Related]

  • 17. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.
    Lehtinen S, Lehtimäki T, Sisto T, Salenius JP, Nikkilä M, Jokela H, Koivula T, Ebeling F, Ehnholm C.
    Atherosclerosis; 1995 Apr 07; 114(1):83-91. PubMed ID: 7605379
    [Abstract] [Full Text] [Related]

  • 18. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 07; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 19. Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia.
    Ojala JP, Helve E, Ehnholm C, Aalto-Setälä K, Kontula KK, Tikkanen MJ.
    J Intern Med; 1991 Nov 07; 230(5):397-405. PubMed ID: 1940775
    [Abstract] [Full Text] [Related]

  • 20. Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese.
    Kitahara M, Shinomiya M, Shirai K, Saito Y, Yoshida S.
    Atherosclerosis; 1990 Jun 07; 82(3):197-204. PubMed ID: 2375785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.